BioVectra Competitors and Similar CompaniesClear all
BioVectra's competitors and similar companies include SiteOne Therapeutics, Inflazome, Isotopen Technologien Munchen and CellOxess.
 BioVectra BioVectra is a biotech and pharmaceutical contract development and manufacturing organization (CDMO). |  SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. |  Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. |  Isotopen Technologien Munchen ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. | ||
Founding Date | Founding Date 1970 | Founding Date 2014 | Founding Date 2016 | Founding Date 2004 | Founding Date 1990 |
Type | Type Private | Type Private | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Charlottetown, CA HQ | Locations San Francisco, US HQ Bozeman, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Garching bei München, DE HQ München, DE | Locations Ewing Township, US HQ |
Employees | Employees 607 | Employees 2216% increase | Employees 156% decrease | Employees 5403% increase | Employees 4 |
Funding | |||||
Latest funding round | Latest funding round $ 39.8m (over 4 years ago) | Latest funding round $ 15m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 22m (about 10 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 77.3m | Total funding raised $ 17.8m | Total funding raised $ 17m | Total funding raised $ 22m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
SiteOne Therapeutics
HQ
San Francisco, US
Employees
22↑ 16% increase
SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View companyInflazome
HQ
Dublin 2, IE
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyIsotopen Technologien Munchen
HQ
Garching bei München, DE
Employees
540↑ 3% increase
ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.
View company
CellOxess
HQ
Ewing Township, US
Employees
4
CellOxess is a company that provides healthcare and biotechnology services.
View company